Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma

Prediction of peritoneal dissemination is very difficult using current diagnostic tools such as computed tomography, ultrasonography, or various tumor markers. The predictive value of serum CA 125 levels for peritoneal metastasis from gastric carcinoma was studied.

[1]  R. Kannagi,et al.  Adhesion molecules and TGF‐β1 are involved in the peritoneal dissemination of NUGC‐4 human gastric cancer cells , 1997 .

[2]  西村重彦.  Role of α2β1-and α3β1-integrin in the peritoneal implantation of scirrhous gastric carcinoma(スキルス胃癌の腹膜播種におけるα2β1-およびα3β1-インテグリンの関与について) , 1997 .

[3]  M. Yashiro,et al.  CD44H Plays an Important Role in Peritoneal Dissemination of Scirrhous Gastric Cancer Cells , 1996, Japanese journal of cancer research : Gann.

[4]  Y. Chung,et al.  Role of alpha 2 beta 1- and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinoma. , 1996, British Journal of Cancer.

[5]  Y. Chung,et al.  Hepatocyte growth factor (HGF) produced by peritoneal fibroblasts may affect mesothelial cell morphology and promote peritoneal dissemination , 1996, International journal of cancer.

[6]  A. Norman,et al.  The prognostic value of serum and immunohistochemical tumour markers in advanced gastric cancer. , 1996, European journal of cancer.

[7]  K. Tsuchihara,et al.  Decreased E-cadherin expression correlates with poor survival in patients with gastric cancer. , 1995, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[8]  J. Balibrea,et al.  Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer , 1995, The International journal of biological markers.

[9]  B. Naylor,et al.  Serum albumin and CA125 are powerful predictors of survival in epithelial ovarian cancer , 1994, British journal of obstetrics and gynaecology.

[10]  Y. Hirai,et al.  Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma. , 1994, Gynecologic oncology.

[11]  Kazutomo Inoue,et al.  Comparison of Survival Curves of Gastric Cancer Patients After Surgery According to the UICC Stage Classification and the General Rules for Gastric Cancer Study by the Japanese Research Society for Gastric Cancer , 1993, Annals of surgery.

[12]  G. Beattie,et al.  The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma. , 1993, British Journal of Cancer.

[13]  Cruickshank Dj,et al.  The potential value of CA125 as a tumour marker in small volume, non-evaluable epithelial ovarian cancer. , 1991 .

[14]  D. Cruickshank,et al.  The potential value of CA125 as a tumour marker in small volume, non-evaluable epithelial ovarian cancer. , 1991, The International journal of biological markers.

[15]  K. Hamamoto,et al.  Serum CA125 level is a good prognostic indicator in lung cancer. , 1990, British Journal of Cancer.

[16]  H. Egami,et al.  Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system. , 1987, Gut.

[17]  C. Haglund.  Tumour marker antigen CA 125 in pancreatic cancer : A comparison with CA 19-9 and CEA , 2007 .

[18]  H. Egami,et al.  Clinical Significance of Serum CA125 Values in Patients with Cancers of the Digestive System , 1986, The American journal of the medical sciences.

[19]  P. Wilkinson,et al.  Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker. , 1984, British Journal of Cancer.

[20]  R. Bast,et al.  Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. , 1984, Cancer research.

[21]  R. Bast,et al.  Tissue Distribution of a Coelomic- Epithelium‐Related Antigen Recognized by the Monoclonal Antibody OC125 , 1983, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[22]  R. Bast,et al.  Reactivity of a monoclonal antibody with human ovarian carcinoma. , 1981, The Journal of clinical investigation.